Generate Biomedicines, Inc. (GENB) vs Nuvation Bio Inc. (NUVB)
- Generate Biomedicines, Inc. GENB 9.83 −6.29%
- Nuvation Bio Inc. NUVB 3.92 +2.08%
Generate Biomedicines, Inc. and Nuvation Bio Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Nuvation Bio Inc. are of similar size ($1.4B and $1.3B). Nuvation Bio Inc. has the higher net margin (−67.4% vs −1,381.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Nuvation Bio Inc. leads on 10 and Generate Biomedicines, Inc. on 5.
Valuation
Profitability
| Metric | GENB | NUVB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.79% | 70.18% |
| Operating margin | (1,382.04%) | (61.17%) | 0.00% |
| Net margin | (1,381.76%) | (67.38%) | 0.00% |
| Free cash flow margin | (1,199.36%) | (53.62%) | 0.00% |
| Return on equity | 1,091.11% | (49.09%) | (50.72%) |
| Return on assets | (56.30%) | (19.70%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack